28 related articles for article (PubMed ID: 29864401)
1. Targeting Aurora B kinase with Tanshinone IIA suppresses tumor growth and overcomes radioresistance.
Li M; Liu H; Zhao Q; Han S; Zhou L; Liu W; Li W; Gao F
Cell Death Dis; 2021 Feb; 12(2):152. PubMed ID: 33542222
[TBL] [Abstract][Full Text] [Related]
2. Treatment of non-Hodgkin's lymphoma xenografts with the HB22.7 anti-CD22 monoclonal antibody and phosphatase inhibitors improves efficacy.
O'Donnell RT; Pearson D; McKnight HC; Ma YP; Tuscano JM
Cancer Immunol Immunother; 2009 Oct; 58(10):1715-22. PubMed ID: 19294384
[TBL] [Abstract][Full Text] [Related]
3. Targeting MYC-driven lymphoma: lessons learned and future directions.
Martínez-Martín S; Beaulieu ME; Soucek L
Cancer Drug Resist; 2023; 6(2):205-222. PubMed ID: 37457123
[TBL] [Abstract][Full Text] [Related]
4. Inhibition of extranodal NK/T-cell lymphoma by Chiauranib through an AIF-dependent pathway and its synergy with L-asparaginase.
Gao T; Huang J; Yin H; Huang J; Xie J; Zhou T; Fan W; Yang X; Gao G; Li Z
Cell Death Dis; 2023 May; 14(5):316. PubMed ID: 37160920
[TBL] [Abstract][Full Text] [Related]
5. Aurora B Inhibitors as Cancer Therapeutics.
Kovacs AH; Zhao D; Hou J
Molecules; 2023 Apr; 28(8):. PubMed ID: 37110619
[TBL] [Abstract][Full Text] [Related]
6. Preclinical Studies of Chiauranib Show It Inhibits Transformed Follicular Lymphoma through the VEGFR2/ERK/STAT3 Signaling Pathway.
Tang Y; Zhong M; Pan G; Tan J; Xie C; Jiang Y; Yao J; Shan W; Lin J; Huang J; Liu Y; Li Z; Xu B; Zha J
Pharmaceuticals (Basel); 2022 Dec; 16(1):. PubMed ID: 36678513
[TBL] [Abstract][Full Text] [Related]
7. CS2164 and Venetoclax Show Synergistic Antitumoral Activities in High Grade B-Cell Lymphomas With
Yuan D; Li G; Yu L; Jiang Y; Shi Y; Chen Q; Ma X; Pham LV; Young KH; Deng M; Fang Z; Xu B
Front Oncol; 2021; 11():618908. PubMed ID: 33777762
[TBL] [Abstract][Full Text] [Related]
8. Chiauranib selectively inhibits colorectal cancer with
Yin H; Xie J; Jiang P; Jiang X; Duan D; Qi J; Luo Z; Ma C; Hong H
Am J Cancer Res; 2020; 10(11):3666-3685. PubMed ID: 33294260
[TBL] [Abstract][Full Text] [Related]
9. Statins as the Controlling Agents for Non-Hodgkin's Lymphomas via Increasing the Casein Kinase 2 Interacting Protein-1: A Hypothesis.
Kazemi K; Mozafari N; Ashrafi H; Rafiei P; Azadi A
Curr Drug Discov Technol; 2020; 17(5):616-618. PubMed ID: 31264550
[TBL] [Abstract][Full Text] [Related]
10. Novel therapeutics for aggressive non-Hodgkin's lymphoma.
Mahadevan D; Fisher RI
J Clin Oncol; 2011 May; 29(14):1876-84. PubMed ID: 21483007
[TBL] [Abstract][Full Text] [Related]
11. CS2164 exerts an antitumor effect against human Non-Hodgkin's lymphomas in vitro and in vivo.
Deng M; Shi Y; Chen K; Zhao H; Wang Y; Xie S; Zhao J; Luo Y; Fang Z; Fan Y; Xu B
Exp Cell Res; 2018 Aug; 369(2):356-362. PubMed ID: 29864401
[TBL] [Abstract][Full Text] [Related]
12. CS2164 suppresses acute myeloid leukemia cell growth via inhibiting VEGFR2 signaling in preclinical models.
Deng M; Zhao H; Chen Q; Zhao J; Shi Y; Yu L; Fang Z; Xu B
Eur J Pharmacol; 2019 Jun; 853():193-200. PubMed ID: 30928630
[TBL] [Abstract][Full Text] [Related]
13. CS2164, a novel multi-target inhibitor against tumor angiogenesis, mitosis and chronic inflammation with anti-tumor potency.
Zhou Y; Shan S; Li ZB; Xin LJ; Pan DS; Yang QJ; Liu YP; Yue XP; Liu XR; Gao JZ; Zhang JW; Ning ZQ; Lu XP
Cancer Sci; 2017 Mar; 108(3):469-477. PubMed ID: 28004478
[TBL] [Abstract][Full Text] [Related]
14. Apatinib exerts anti-tumor activity to non-Hodgkin lymphoma by inhibition of the Ras pathway.
Wang Y; Deng M; Chen Q; Li Y; Guo X; Shi P; He L; Xie S; Yu L; Zhang H; Xu B
Eur J Pharmacol; 2019 Jan; 843():145-153. PubMed ID: 30423319
[TBL] [Abstract][Full Text] [Related]
15. Antitumor activity of TY-011 against gastric cancer by inhibiting Aurora A, Aurora B and VEGFR2 kinases.
Liu W; Lu Y; Chai X; Liu X; Zhu T; Wu X; Fang Y; Liu X; Zhang X
J Exp Clin Cancer Res; 2016 Nov; 35(1):183. PubMed ID: 27887633
[TBL] [Abstract][Full Text] [Related]
16.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
17.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
